Tyra Biosciences, Inc. Net Income Loss

• Tyra Biosciences, Inc. showed a decrease of -38.7% in Net Income Loss from 2024 to 2025.
• This data is from Tyra Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 2, 2026.
• XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 6 years of available data (2020 to 2025), Tyra Biosciences, Inc.'s Net Income Loss has declined by 1,184.8%.
• Historical annual values: Fiscal year 2025: -$119.95 million | Fiscal year 2024: -$86.48 million | Fiscal year 2023: -$69.13 million | Fiscal year 2022: -$55.33 million | Fiscal year 2021: -$26.29 million | Fiscal year 2020: -$9.34 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026